{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-022762","form_type":"8-K","ticker":"XTNT","cik":"0001453593","company_name":"Xtant Medical Holdings, Inc.","filed_at":"2025-08-08T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.021017+00:00","generated_at":"2026-05-17T16:19:31.883862+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Xtant Medical sets Nov 7, 2025 for annual meeting; proposal deadline Aug 18, 2025","bullets":["Annual meeting scheduled for November 7, 2025; proxy statement expected around September 12, 2025.","Stockholder proposals for proxy inclusion under Rule 14a-8 must be received by August 18, 2025.","Director nominations and other proposals (non-Rule 14a-8) also due by August 18, 2025.","Universal proxy rule (Rule 14a-19) compliance deadline for nominees is September 8, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-022762","json":"https://secwatch.observer/filing/0001641172-25-022762.json","markdown":"https://secwatch.observer/filing/0001641172-25-022762.md","text":"https://secwatch.observer/filing/0001641172-25-022762.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1453593/000164117225022762/0001641172-25-022762-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1453593/000164117225022762/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T16:19:31.883862+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}